Methenolone Enanthate (303-42-4) Manufacturer - Buyaas

Methenolone Enanthate (303-42-4)

November 8, 2018

Methenolone Enanthate (also known as primobolan depot) is an injectable anabolic steroids which shows mild anabolic and low androgenic properties, it belong to the dihydrotestosterone (DHT) group. The enanthate ester creates a situation in which concentrations of the steroid rises and stays elevated for roughly two weeks.

 


Status: In Mass Production
Unit: 25kg/Drum
Capacity: 1240kg/month

Methenolone Enanthate (303-42-4) video

 

Methenolone Enanthate (303-42-4) Description

Methenolone Enanthate (also known as primobolan depot) is an injectable anabolic steroids which shows mild anabolic and low androgenic properties, it belong to the dihydrotestosterone (DHT) group. The enanthate ester creates a situation in which concentrations of the steroid rises and stays elevated for roughly two weeks. It can be used for the treatment of muscle wasting diseases, osteoporosis and sarcopenia as well as prolonged corticosteroid exposure. In some cases, it is also effective in the treatment of carcinoma and hepatitis. Metenolone enanthate was introduced for medical use in 1962. It also can be used to improve physique and performance.

 

Methenolone Enanthate (303-42-4) Specifications

Product Name Methenolone Enanthate
Chemical Name Primobolan depotDelapromor, Methenolone enanthat
Brand Name Primobolan Depot, Nibal Injection
Drug Class Androgen; Anabolic steroid; Androgen ester
CAS Number 303-42-4
InChIKey TXUICONDJPYNPY-FRXWOFFRSA-N
Molecular Formula C27H42O3
Molecular Weight 414.62
Monoisotopic Mass 414.313 g/mol
Melting Point  67ºC~ 68ºC
Freezing Point No date available
Biological Half-Life IM: 10.5 days
Color White crystalline solid
Solubility  water insoluble

Soluble in methanol and chloroform

Storage Temperature  -20°C
Application An injectable anabolic and androgenic steroid.

 


=

Reviews

There are no reviews yet.

Be the first to review “Methenolone Enanthate (303-42-4)”

Your email address will not be published.